Efficacy and Safety Study of TJCS for Treatment of Moderate to Severe Dry Eye Syndromes

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of this clinical Study is TJCS Eye Drops 0.05%(Cyclosporine ophthalmic nano-emulsion) group and Restasis Eye Drops 0.05%(Cyclosporine ophthalmic suspension) group 12 weeks after treatment, each treatment group comparisons for evaluation of efficacy and safety in Moderate to Severe Dry Eye Disease.
Epistemonikos ID: 1ebc4f27b399a447b7b144dd23b1aedf426b3b92
First added on: May 12, 2024